David Horrobin Bibliography
Ally, A.I. and Horrobin, D.F.
Thromboxane A2 in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension
Prostaglandins Med 1980; 4(6): 431-8.

Ally, A.I. and Horrobin, D.F.
16, 16 dimethyl PGE2: evidence that it has properties different from the parent compound in vascular smooth muscle
Prostaglandins Med 1980; 5(1): 39-43.

Cunnane, S.C. and Horrobin, D.F.
Parenteral Linoleic and gamma-linolenic acids ameliorate the gross effects of zinc deficiency
Proc Soc Exp Biol Med 1980; 164(4): 583-8.

Cunnane, S.C.; Horrobin, D.F.; Manku, M.S.; Oka, M.
The vascular response to zinc varies seasonally: effect of pinealectomy and melatonin
Chronobiologia 1980; 7(4): 493-503.

Cunnane, S.C.; Manku, M.S.; Oka, M.; Horrobin, D.F.
Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin
Can J Physiol Pharmacol 1980; 58(3): 287-93.
(Full text)  (Abstract)

Cunnane, S.C.; Sella, G.E.; Horrobin, D.F.
Essential fatty acid supplementation inhibits the effect of dietary zinc deficiency
Adv Prostaglandin Thromboxane Res 1980; 8: 1797-8.

Horrobin, D.F.
Schizophrenia: a biochemical disorder?
Biomedicine 1980; 32(2): 54-5.

Horrobin, D.F.
Prolactin as a regulator of fluid and electrolyte metabolism in mammals
Fed Proc 1980; 39(8): 2567-70.

Horrobin, D.F.
In: Hemmings, G. (Ed.) Biochemistry of scizophrenia and addiction, MTP Press Ltd. 1980: xiii.

Horrobin, D.F.
Niacin flushing, prostaglandin E and evening primrose oil. A possible objective test for monitoring therapy in schizophrenia [letter]
J Orthomolecular Psychiatry 1980; 9: 33-34.

Horrobin, D.F.
Prostaglandins and schizophrenia [letter]
Lancet 1980; 1(8170): 706-7.

Horrobin, D.F.
The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1
Med Hypotheses 1980; 6(5): 469-86.

Horrobin, D.F.
A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2
Med Hypotheses 1980; 6(8): 785-800.

Horrobin, D.F.
A biochemical basis for alcoholism and alcohol-induced damage including the fetal alcohol syndrome and cirrhosis: interference with essential fatty acid and prostaglandin metabolism
Med Hypotheses 1980; 6(9): 929-42.

Horrobin, D.F.
A revolutionary concept of the role of the nucleolus in cell division and its relevance to stem cell proliferation, cancer and ageing
Med Hypotheses 1980; 6: 1217-1218.

Horrobin, D.F.
The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of 1 and 2 series prostaglandins: relevance to inflammation and immunity
Medical Hypotheses 1980; 6: 687-709.

Horrobin, D.F.
A singular solution for schizophrenia
New scientist 1980; 85(1196): 642-644.

Horrobin, D.F.
Whither medicine? Nemesis or not? A reply to Ivan Illich
World Health Forum 1980; 1(1,2): 139-141.

Horrobin, D.F. and Campbell, A.
Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C
Med Hypotheses 1980; 6(3): 225-32.

Horrobin, D.F. and Cunnane, S.C.
Interactions between zinc, essential fatty acids and prostaglandins: relevance to acrodermatitis enteropathica, total parenteral nutrition, the glucagonoma syndrome, diabetes, anorexia nervosa and sickle cell anaemia
Med Hypotheses 1980; 6(3): 277-96.

Horrobin, D.F. and Manku, M.S.
Possible role of prostaglandin E1 in the affective disorders and in alcoholism
Br Med J 1980; 280(6228): 1363-1366.
(Full text)  (Abstract)

Horrobin, D.F. and Manku, M.S.
Chlorpropamide/alcohol flushing and prostaglandins [letter]
Lancet 1980; 1(8174): 935-6.

Horrobin, D.F.; Manku, M.S.; Oka, M.; Cunnane, S.C.
The role of a prostaglandin E1 deficiency in schizophrenia: interactions with dopamine and opiates
In: Hemmings, G. (Ed.) Biochemistry of scizophrenia and addiction, MTP Press Ltd. 1980: 3-18.

Horrobin, D.F.; Manku, M.S.; Oka, M.; Cunnane, S.C.
Selective control of formation of 1 and 2 series prostaglandins: a new concept in the regulation of inflammation and immunity
Inflammation: Mechanisms and Treatment. Proceedings of the Fourth International Meeting on Future Trends in Inflammation. University Park Press, Baltimore. 1980: 267-283.

Horrobin, D.F. and Morgan, R.O.
Myotonic dystrophy: a disease caused by functional zinc deficiency due to an abnormal zinc-binding ligand?
Med Hypotheses 1980; 6(4): 375-84.

All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact